Switching from Vyvanse 50mg to Ritalin
When switching an adult patient from Vyvanse (lisdexamfetamine) 50 mg to Ritalin (methylphenidate), start with methylphenidate 10 mg twice daily (morning and noon) and titrate upward by 5-10 mg increments weekly based on response, with a typical target range of 20-40 mg total daily dose.
Rationale for Starting Dose
The evidence does not provide direct conversion ratios between lisdexamfetamine and methylphenidate because they are different stimulant families (amphetamine vs. methylphenidate) with distinct pharmacokinetic profiles 1. Starting conservatively with methylphenidate 10 mg twice daily allows you to assess tolerability and efficacy without risking overstimulation 2.
Titration Strategy
- Week 1: Start methylphenidate immediate-release 10 mg in the morning and 10 mg at noon (total 20 mg/day)
- Week 2-4: Increase by 5-10 mg increments weekly based on symptom control and side effects
- Target dose: Most adults respond to 20-40 mg total daily dose, though some may require up to 60-65 mg/day 2
- Timing: Administer at breakfast and lunch to minimize insomnia 3
Key Considerations
Expect potential need for adjustment: Research shows that 41% of medication-naive adults with ADHD require switching between stimulant families due to poor tolerability 4. Since your patient is switching from an amphetamine product, monitor closely for differences in response profile.
Monitor for common side effects: Agitation and insomnia are most frequent, followed by decreased appetite, headaches, and irritability 3. Methylphenidate has a shorter half-life (2 hours) compared to lisdexamfetamine's 12-hour duration 2, 1, so withdrawal symptoms from the amphetamine may overlap with methylphenidate initiation during the first few days.
Formulation Options After Stabilization
Once an effective total daily dose is established with immediate-release methylphenidate, consider converting to extended-release formulations for convenience:
- Add morning and noon doses together for the extended-release equivalent
- Example: If stabilized on 15 mg morning + 15 mg noon = 30 mg extended-release once daily 2
Critical Pitfalls to Avoid
Do not attempt a direct mg-to-mg conversion. Vyvanse 50 mg is not equivalent to methylphenidate 50 mg. The medications have different potencies and mechanisms (lisdexamfetamine is a prodrug requiring conversion to dextroamphetamine) 1, 5.
Do not abruptly stop Vyvanse without overlap. While stimulants don't require tapering for safety, consider starting methylphenidate the day after the last Vyvanse dose to avoid a treatment gap that could impair function.
Screen for cardiovascular contraindications before initiating methylphenidate, particularly uncontrolled hypertension, coronary artery disease, or tachyarrhythmias 3.
When to Consider Alternative Approaches
If the patient experiences prohibitive side effects (severe anorexia, severe insomnia >1.5 hours, severe anxiety, or hallucinations) or inadequate response after 4 weeks at optimal doses, consider switching back to an amphetamine product or transitioning to non-stimulant options like atomoxetine 6, 2.